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Microarray technology has revolutionized genomic studies by enabling the study of differ-
ential expression of thousands of genes simultaneously. The main objective in microarray
experiments is to identify a panel of genes that are associated with a disease outcome or
trait. In this thesis, we develop and evaluate a semi-parametric copula-based algorithm
for gene selection that does not depend on the distributions of the covariates, except that
their marginal distributions are continuous. A comparison of the developed method with
the existing methods is done based on power to identify differentially expressed genes
(DEGs) and control of Type I error rate via a simulation study. Simulations indicate
that the copula-based model has a reasonable power in selecting differentially expressed
gene and has a good control of Type I error rate. These results are validated in a publicly-
available melanoma dataset. The copula-based approach turns out to be useful in finding
genes that are clinically important. Relaxing parametric assumptions on microarray data
may yield procedures that have good power for differential gene expression analysis.
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1.1 Background of Microarray Technology
Microarray technology has revolutionized genomic studies by enabling the study of differ-
ential expression of thousands of genes simultaneously. The main objective in microarray
experiments is to identify a panel of genes that are associated with a disease outcome or
trait. Microarray technology has increasingly gained application in biological and medical
research, where their main application is in the classification of cells (tumor or normal
cell). This section describes the biology of gene expression and how gene expression data
is produced and processed. We also provide an extensive review of the existing statistical
approaches available for the analysis of microarray data.
1.1.1 Biology of Gene Expression
Cells are the fundamental working units of every living organism. Their growth and divi-
sion are controlled by the activity of the deoxyribonucleic acid (DNA). A DNA molecule
is a double-stranded polymer composed of four basic molecular units called nucleotides.
DNA from all organisms is made up of the same chemical and physical components. A
DNA sequence is a particular arrangement of the base pairs in the DNA strand. The
entire DNA sequence that codes for a living thing is called its genome. The genome does
not function as one long sequence, but is divided into a set of genes. A gene is a segment
of DNA that directs the synthesis of a protein. The expression of the genetic informa-
tion stored in the DNA molecule occurs in two stages: (i) transcription, where the DNA
molecule is transcribed into a ribonucleic acid (RNA); and (ii) translation, where RNA is
translated into proteins that perform various cellular functions. These two processes de-
scribe the central dogma of biology which states that DNA makes RNA and RNA makes
1
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protein (See Figure 1.1 ). The process of transcribing a gene’s DNA sequence into RNA
is called gene expression. A gene’s expression level indicates the approximate number of
copies of that gene’s RNA that is produced in a cell. The measurements of the expression
levels have been made easy with the introduction of microarray experiments.
Figure 1.1: The Central Dogma of Molecular Biology: DNA makes RNA
makes proteins. Image downloaded from http://www.atdbio.com/content/14/
Transcription-Translation-and-Replication\figure-central-dogma
1.1.2 Microarray Experiment and Expression Data Generation
There are two types of microarray experiments: cDNA and oligonucleotide microar-
rays. The main difference between the two types of microarrays is in the components or
molecules of DNA that are involved in the hybridization process. For cDNA microarrays,
both the targets and probes are the cDNA molecules, while for the oligonucleotide arrays
the targets are cDNA molecules and the probes are well-chosen small segments of cDNA,
known as oligos. A sketch of the cDNA microarray technology is provided in Figure 1.2.
Here, selected probes are amplified through the polymerase chain reaction (PCR) and the
PCR product is printed to a glass slide using a high-speed robot. The glass slides consist
of thousands of spots. Then mRNA are experimentally extracted from normal and tu-
mor cells or reference and test cells, respectively. These are converted to cDNA through
reverse-transcription, amplified by PCR and labeled using two florescent dyes (Cynine 3
or Cy3 (green) and Cynine 5 or Cy5 (red)). Test (tumor) cells are usually labeled with
Cy5. These are mixed in equal proportions and allowed to hybridize with cDNA spotted
in the glass slide. Once the hybridization is completed, the slides are washed and scanned
with a scanning laser microscope, which is able to measure the brightest of each florescent
spot. Brightness reveals how much of a specific DNA fragment is present on the target.
Each spot represents a gene. Grey spots denote genes that were expressed in neither type
of cell, while colored spots identify genes that were expressed in one of the cells or both.
2
Chapter 1. Introduction
The intensity of the color of the spot discloses the relative expression of the gene in the
two cells. Usually a measurement scale is provided to associate each color tone with a
log-transformed ratio between the expression levels in the two cells. The resultant data
matrix consists of gene expression levels (rows) and replicated experiments (columns).
Figure 1.2: Overview of a cDNA microarray experiment. Image downloaded from http:
//www.microarray.lu/en/MICROARRAY_Overview.shtml
1.1.3 Preprocessing of Microarray Data
Data preprocessing in microarrays is done with the aim of reducing data variability and
dimensionality (Sebastiani et al., 2003). Two processes are involved in preprocessing:
normalization and filtering on either raw data or transformed data.
The goal of normalization is to remove systematic distortion across microarrays to
render comparable the experiments conducted under different conditions. Normalization
techniques can be used either locally or globally. Global normalization uses all genes in
the microarray to identify a transformation of the expression while the local normalization
uses only the house keeping genes (genes known to remain constantly expressed in different
experimental conditions).
The goal of filtering is to reduce variability by removing genes that have measurements
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that are not sufficiently accurate and to reduce dimensionality of the data by removing
gene that are not sufficiently differentiated. The choice of genes to be removed can differ
substantially according to the microarray platform and the technique chosen for analysis.
For cDNA microarrays, genes with negative or small expression values are removed while
for the Affymetrix platform, all genes labeled A (Absent) or M (Minimal) are removed.
Transformation of raw data is recommended since the corrected intensity values are
highly skewed. It is assumed that log transformation produces normally distributed data
(Nadon and Shoemaker, 2002). The best transformation method is still an open problem
though.
1.1.4 Identification of Differentially Expressed Genes
A gene is differentially expressed if its expression level is associated with a response or
a covariate of interest. The covariates could be the type of cell, the type of drug, etc.,
while responses could be survival time or any other clinical outcome in the context of
other clinical studies.
Microarray data analysis methods can be subdivided into two broad categories: unsu-
pervised and supervised methods. Unsupervised analysis or class discovery is an unbiased
analysis of microarray data. No prior phenotype information is used and clustering meth-
ods are used to group the samples based solely on the microarray data. In a supervised
analysis (also called class prediction), previous knowledge is taken into account. Its aim
is to identify genes or develop a model that is able to assign patients to different classes
based on the microarray data. Ding (2003) proposed and studied an unsupervised method
to select relevant genes based on their similarity information only. The method relied
on a mechanism for discarding irrelevant genes. When applied to expression profiles of
colon cancer and leukemia, their unsupervised method selected relevant genes close to
those selected using supervised methods. The existing literature on the application of
discriminant and cluster analyses include Eisen et al. (1998) and Golub (1999). Eisen
et al. (1998) used cluster analysis to find patterns of gene expression. However, they did
not develop methods for modelling gene expression levels through a suitable statistical
model. Even though they are limited in their applications, unsupervised methods are
still used for pattern discovery and dimension reduction.
Supervised methods can further be classified as parametric, non-parametric and semi-
parametric statistical methods. For any statistical method to be useful, it must have the
following characteristics: ability to quantify the degree of association and the correspond-
ing statistical significance between each gene expression level and the outcome of interest
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(covariate); the ability to control the overall error rate; and robustness against outliers
and model misspecification (Jung et al., 2005).
Among the early methods used was the fold-change method (DeRisi et al., 1996;
Schena et al., 1996). This approach identifies genes as differentially expressed if the differ-
ence in expression levels between two conditions is greater than some specified threshold.
This method has an advantage of being simple. However, it is known to be unreliable
because statistical variation is not taken into account. It is also subject to bias if the
data is not properly normalized (Sreekumar, 2008).
A number of parametric approaches exists in the literature. The most common and
a straightforward approach is the traditional t-test for two samples. It compares the
difference between two means in relation to the variation in the data. Its advantage over
the fold-change method is that, it is easy to calculate p-values and confidence intervals
(Bair, 2013). However, it has challenges when applied to data with small sample size.
In particular, there is overestimation of variance when the sample size is small. Some of
these parametric models have been assessed for goodness-of-fit to automatically detect
outliers that possess too large deviation from the overall pattern (Li and Wong, 2001).
Given the challenges faced by t-test, a number of authors have proposed alternative
methods to identify differentially expressed genes. Bayesian statistical methods have been
developed for differential gene expression with a view to, inter italia, finding significant
genes or gene signatures in large oncological microarray studies. These methods com-
bine information across genes to avoid inaccurate variance estimates as a result of small
sample sizes (Bair, 2013). Baldi and Long (2001) developed a Bayesian probabilistic
framework for microarray data analysis. They modeled log-expression values by inde-
pendent normal distributions, parameterized by corresponding means and variances with
hierarchical prior distributions. Simulations showed that point estimates, combined with
a t-test, provided a systematic inference approach that compared favorably with simple
t-test or fold methods, and partly compensated for the lack of replication. Newton et al.
(2001) described a version of parametric Empirical Bayes (EB) analysis for spotted mi-
croarrays and was restricted to the single-slide data in which each gene produces two
measurements, one from each cell condition. Ibrahim et al. (2002) developed a Bayesian
model for analyzing microarray data and used it to identify a subset of genes that are
differentially expressed between normal and cancer cells. Lee et al. (2003) developed hi-
erarchical Bayesian models for gene selection for binary data and applied the method to
cancer classification via cDNA microarrays to identify significant genes. Extending Lee
et al. (2003) work, Kendziorski et al. (2003) proposed a general EB modelling approach
which allows for replicate expression profiles in multiple conditions. The hierarchical
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mixture model accounts for differences among genes in their average expression levels,
differential expression for a given gene among cell types, and measurement fluctuations.
Smyth (2004) proposed a linear model for microarray (LIMMA) method that uses em-
pirical Bayes test statistic. Scharpf et al. (2009) developed hierarchical Bayesian models
for gene selection for binary data collected from different studies, and used it to identify
significant genes. They applied their model to four breast cancer studies using differ-
ent technologies (cDNA and Affymetrix) to estimate differential expression in estrogen
receptor-positive tumors versus estrogen receptor-negative tumors. Results from their
study showed a strong evidence that borrowing strength across both genes and studies
can be effective in the analysis of multiplatform studies. Bayesian methods have proven
to be very efficient in situations where the number of observations is small, as is the
case for most microarray studies (Jeffery et al., 2006). However, Bayesian models do not
distinguish genes with low levels of differential expression from those with no differential
expression well (Scharpf et al., 2009).
A class of non-parametric methods has been proposed to identify DEGs. This is where
the distribution of random errors are estimated without parametric assumptions. This
idea has been proposed by a number of researchers. Tusher et al. (2001) used the sta-
tistical analysis of microarrays (SAM) method, which identified genes with statistically
significant changes in expression. This method assigns a score to each gene on the basis
of change in gene expression relative to the standard deviation of repeated measures.
For genes with scores greater than an adjustable threshold, SAM uses permutations of
the repeated measurements to estimate the percentage of genes identified by chance, the
false discovery rate (FDR). This method is capable of addressing problems with the fold-
change approach but the estimation of variance can be affected if a small sample size
is used. Efron et al. (2001) applied a non-parametric EB method in order to identify
DEGs. Their method used a simple non-parametric mixture prior to model the pop-
ulation of genes affected by radiation or not, thereby avoiding parametric assumptions
about gene expression. They found a close connection between the estimated posterior
probabilities and a local version of the FDR, thereby allowing for the analyst to han-
dle multiple testing issues that arise when dealing with a large number of simultaneous
tests. Le et al. (2003) proposed a non-parametric statistical approach, called the mix-
ture model method (MMM), to handle the problem when there are a small number of
replicates under each experimental condition. They compared their method with SAM
and showed that their method was better than the SAM approach. Pan (2003) proposed
a non-parametric method to detect differential gene expression for replicated microarray
experiments conducted under two conditions. Their method aimed at constructing a null
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statistic that estimates a null distribution of a test statistic directly. They assessed their
method with the existing methods when applied to the SAM, the MMM and the EB
methods. In the process, they compared the performances of the three methods (SAM,
MMM, EB) with each other. They showed that the SAM method was more robust to
the use of the null statistic than the MMM method. They also showed that their method
performed better than the existing methods in approximating the null distribution of
the test statistic. However, their results were comparable to the existing methods when
applied to the real dataset.
Semiparametric models have also been used to analyze gene expression data. Dhanasekaran
et al. (2001) applied a method that identified a prognostic gene with a p-value calculated
by fitting a Cox regression model without adjusting for multiplicity of the original genes.
Wigle et al. (2002) used the Cox proportional hazards model to determine patterns of
gene expression segregating with clinical outcome. They fitted a univariate Cox regres-
sion model on each gene expression level and adjusted p-values for the multiple testing
procedure based on Dubey’s approach (Dubey (1994)). However, Cox regression methods
may not be robust in the presence of outliers (Owzar et al., 2007).
Newton et al. (2004) proposed a semiparametric hierarchical mixture method (HMM)
to detect differentially expressed genes. Compared to several competing methodologies,
their methodology exhibited good operating characteristics in a simulation study, on the
analysis of spike-in data, and in a cross-validation calculation. Owzar et al. (2007) pro-
posed a copula model for differential gene expression. This model assumes a parametric
dependence between individual gene and time to event outcome. It was developed to iden-
tify individual gene expression associated with the time-to-event outcome. This method
adequately controlled family wise error rate (FWER).
A number of authors have compared and evaluated the performances of different
methods for gene expression analysis. These include (Dudoit et al., 2002; Troyanskaya
et al., 2002; Schwender et al., 2003; Qin and Kerr, 2004; Jeffery et al., 2006; Kim et al.,
2006; Sreekumar, 2008; Jeanmougin et al., 2010; Bair, 2013; Bandyopadhyay et al., 2014).
Troyanskaya et al. (2002) addressed in their study the problem of robust identification of
differentially expressed genes from a microarray data. They compared the performance
of three non-parametric tests: non-parametric t-test, Wilcoxon rank-test and a heuristic
method based on rank-sum test. They showed that all the methods exhibited low false
positive rates but the rank-sum test proved to be the most conservative method. Jeffery
et al. (2006) compared 10 methods to find differentially expressed genes on 9 different
datasets. They reported that the classification success of the methods are influenced by
the feature selection method, the number of genes in the genelist, the number of cases
7
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(samples) and the noise in the dataset. Bair (2013) discussed a number of statistical
methods, including fold change, methods based on t-test and Bayesian methods that can
be used to find differentially expressed genes. However, he did not compare their perfor-
mance on any dataset. Bandyopadhyay et al. (2014) compared a number of parametric
and non-parametric tests based on simulated datasets. They concluded that the selec-
tion of genes depends on the choice of statistical technology and that the performance
of the methods are affected by the samples size, number of replicates and distributional
assumptions among other factors.
Identification of DEGs from combined microarray studies have also been common.
Conlon et al. (2007) integrated information from different studies using a joint stochastic
model for the available data. Scharpf et al. (2009) adopted Conlon et al. (2007) work
and developed a hierarchical Bayesian model for gene selection for binary data collected
from different studies, and used it to identify important genes expression. Their study
assumed that the genes are independent. This approach of combining data from several
independent microarray studies is termed as “microarray meta-analysis” (Tseng et al.,
2012). Heterogeneity across studies is a major concern in carrying out microarray meta-
analysis. Normalizing across studies and directly merging datasets for differentially gene
analysis is one way of handing heterogeneity. This approach, however, restrict selection of
studies from same or similar array platforms (Tseng et al., 2012). Other existing methods
for carrying out a microarray meta-analysis include: combining p-values, combining effect
sizes, combining ranks and combining latent variables.
1.2 Error Rate Control in Microarray Studies
A typical microarray experiment involves testing several hypotheses simultaneously. In
this case, the probability of Type I error increases with the increase in the number of
hypothesis to be tested. A global test of significance should therefore be conducted to
determine if there is any significant value in the set of estimated parameters. Adjusting
the p-value for the number of hypotheses implies controlling for Type I error.
Control of Type I error rate under multiple testing was initially done using family wise
error rate(FWER) by Westfall and Young (1993). Among the first authors who adopted
this method to identity differentially expressed gene was Dudoit et al. (2002). The FWER
has been a useful approach in controlling Type I error, however, it is too conservative.
This shortfall led to the development of an alternative method, the false discovery rate
(FDR). FDR was developed by Benjamini and Hochberg (1995) as an improvement on
the FWER approach. FDR is defined as the expected false discoveries among all the tests
8
Chapter 1. Introduction
that are called significant.
Table 1.1: Possible outcomes for testing G hypotheses for significance
Null True (H0) Alternative True (H1) Total
Tests not Significant U T G−R
Tests called Significant V S R
Total G0 G−G0 G
In Table 1.1, assume there are G hypotheses to be tested, R is the number of rejected
hypothesis and G0 is the number of true null hypotheses (an unknown parameter). G−G0
is the number of true alternative hypotheses, V is the number of false positives (Type I
error) (also called “false discoveries”) and S is the number of true positives (also called
“true discoveries”). T is the number of false negatives (Type II error), U is the number
of true negatives and R = V + S is the number of rejected null hypotheses (also called








A number of authors have worked on FDR (Yekutieli and Benjamini, 1999; Efron et al.,
2001; Storey, 2002; Storey and Tibshirani, 2003; Schwartzman et al., 2008; Schwartzman
and Lin, 2011), among others.
For microarray studies, the positive false dicovery rate (pFDR) is preferred to other
methods of controlling error. Storey (2002) introduced the q-value, which is the pFDR
analogue of the p-values. They argued that the pFDR and the q-value were the most
appropriate false discovery rate quantities to use . Storey and Tibshirani (2003) modified
Benjamini and Horchberg’s approach by estimating π0. π0 is the overall proportion of
true null hypothesis in the study and 1− π0 is the proportion of significant results in the
study. He showed that π0 = 1 in Benjamini and Horchberg’s approach.
The procedure below outline the steps followed in estimation of q-values given a list
of p-value (Storey and Tibshirani, 2003).
1. Let p(1) ≤ p(2) ≤ ...p(G) be the ordered p- values. This also denotes the ordering of
the features in terms of their evidence against the null hypothesis.





3. Let f̂ be the natural cubic spline with 3 df of π̂0(λ) on λ
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4. Set the estimate of π0 to be π̂0 = f̂(1) .
5. Calculate q̂(p(G)) = π̂0p(G).








7. The estimated q-value for the ith most significant feature is q̂(p(i)).
1.3 Statement of the Problem
Despite all the proposed methods mentioned above, there is no unanimous agreement on
any particular gene selection method. Some of the methods require normality assump-
tions, which may be violated in practice. Furthermore, most methods were developed
for finding differentially expressed genes based on groups or class prediction based on
discrete categories. However, there are some outcomes of interest that are continuous in
nature.
There is need to develop more methods that take into account continuous outcomes
and at the same time relax the normality assumptions. In this work, we propose a semi-
parametric approach that does not rely on the normality assumption for the marginal
distributions.
1.4 Objectives of the Study
The main aim of this study is to develop a copula model for variable selection in high-
dimensional data (large p, small n) and apply it in differential gene expression analysis
from microarray studies.
The specific aims of this study are to:
(i) Review and compare methods for differential gene expression analysis with regard
to a quantitative outcome.
(ii) Develop and apply a copula model to obtain prognostic gene signatures that are
associated with a quantitative trait.





This thesis is organised in chapters. The content of the remaining chapters are summa-
rized as follow:
In Chapter 2, a review and evaluation of methods for finding differentially expressed
genes in the presence of a quantitative outcome is performed. Four methods are discussed
and applied on both simulated and a real dataset to asses their performance.
In Chapter 3, we introduce a copula model. Families of copulas are also described
as well as the available methods of choosing the “best” copula in terms of goodness-of-fit.
Some areas of applications are also discussed briefly. In Chapter 4, we develop a copula-
based algorithm for finding differentially expressed genes. Simulated datasets are used
to asses the power of the developed copula approach. We then apply it to a melanoma
dataset for validation.
In Chapter 5, the copula-based approach developed in chapter 4 is compared with
the quantitative trait analysis (QTA) method for finding differentially expressed genes
based on power and control of Type I error rate using simulated datasets. A summary of





Microarray technology has revolutionized genomic studies by enabling the study of dif-
ferential expression of thousands of genes simultaneously. In the recent past, a number of
statistical methods have been developed for class comparison and prediction, based on the
gene expression profiling of tumors, cell-types, etc. One of the early methods developed
was the fold-change method. This method did not account for statistical variation across
the samples and suffered from bias if the data are not properly normalized (Sreekumar,
2008).
A number of articles have provided a survey of different statistical methods for finding
differentially expressed genes (DEGs). See Chapter 1 Section 5.2 for more information.
Despite all the surveys mentioned above, there is no unanimous agreement on any partic-
ular gene selection method as the standard. A review and comparison of the statistical
methods may provide bioinformaticians and other biomedical researchers with a useful
guide for choosing the right method for the right data in differential gene expression
analysis. Furthermore, even though work has been done on the development of methods
for the differential analysis of gene expression data measured in two conditions, open
research questions still exist regarding the analysis of gene expression data in which the
training signal is a continuous variable.
This chapter reports a comparative review of four methods: the SAM, the LIMMA,
the lassoed principal components (LPC) and the quantitative trait analysis (QTA) and
their comparison in identifying genes that are associated with a continuous outcome from
the systems biology of melanoma, using a larger number of melanoma cell-lines than
reported in Kaufmann et al. (2008). While the comparison of some of these methods has
been done, most of them concentrated on finding gene signatures based on two groups.
A comparison of the LPC method with other methods is conspicuously missing in almost
12
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all the surveys presented in the literature. Furthermore, the available studies do not
assess the biological and clinical significance of genes generated by theses methods. Our
study attempts to fill this gap in the literature. The comparison is based on the size and
the statistical assessment of the predictive and the prognostic properties of the genelists
produced by these methods.
2.2 Review of Some Statistical Methods for Microar-
ray Data
Most of the methods discussed were developed to identify genes that are expressed in
varying biological conditions. In this section, we do an elaborate review of some of the
commonly used methods that allow detection of differentially expressed genes with respect
to a quantitative outcome.
2.2.1 Statistical Analysis of Microarrays (SAM)
The SAM method was originally developed to identify genes that are differentially ex-
pressed by incorporating a set of gene-specific t-tests. Although Tusher et al. (2001)
analyzed a two-state experiment (with a dichotomous covariate or response), the SAM
procedure can be applied to studies with continuous responses as well. The SAM method
identifies DEGs by use of gene-specific moderated t-tests on the basis of the regression
coefficient relative to the standard deviation of repeated expression measurements for
that gene. SAM employs the false discovery rate (FDR) to control for the multiple test-
ing problem and estimates the FDR through the permutation of values of the response
variable and the moderated t-tests.
Let xij be the expression level for the i
th gene from the jth sample and yj be the
covariate for the jth sample. The linear model of analysis can be expressed as
xij = βi0 + βi1yj + εij, i = 1, 2, ..., G, j = 1, 2, .., n. (2.1)
Here, we assume that
εij ∼ N(0, σ2i ), i = 1, ..., G, j = 1, ..., n. (2.2)
Essentially, the procedure assigns a score, d(i), to each gene, on the basis of the regression
coefficient relative to the standard deviation of repeated expression measurements for that
gene. The score, d(i), is defined as
13





where bi and si are the estimates of βi1 and the standard error of bi, respectively.
bi =
∑
j yj(xij − x̄i)∑













x̂ij =β̂i0 + biyj
β̂i0 =x̄i − biȳ.
(2.7)
s0 is a small positive constant called the fudge factor, which is added to si in order to
minimize the coefficient of variation. This is calculated as a quantile of the standard
deviations, si. Efron et al. (2001) show that the optimum value of s0 derived by cross-
validation is the 90-th percentile of the distribution of the sample variance.
To find genes that are associated with the continuous outcome, the score d(i) is
calculated first from the original data and the values of d(i) are ranked to obtain the
observed order statistics d(1) ≤ d(2) ≤ . . . ≤ d(G). The distribution of the d(i) under
null hypothesis is unknown and is hence estimated by taking B permutations of the
covariate and calculating the permuted expression scores dp(i), p = 1, ..., B. The expected









(i). For a given threshold ∆, significant genes are identified as those for
which |d(i) − d̄(i)| ≥ ∆. ∆ is chosen by cross-validation, as discussed in Tibshirani et al.
(2003). Since some of the significant genes are identified by chance, an estimate of the





∣∣∣∣∣ R > 0
)
P (R > 0), (2.8)
where V is the number of false positives and R is the number of genes declared significant
(Benjamini and Hochberg, 1995). Let
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d0 = max
d(i)≤d̄(i)−∆




d(i) = cutup(∆). (2.10)










where π̂0 is an estimate of prior probability of no differential gene expression (Schwender





The SAM method is implemented in the R package called samr.
2.2.2 Linear Models for Microarray Analysis (LIMMA)
LIMMA is an R package that integrates a number of statistical methods to effectively
analyse large gene expression data (Smyth, 2005). LIMMA fits a linear model for each
gene, given a series of arrays, and uses the EB (Efron et al., 2001) method to estimate
posterior variance for each gene (Smyth, 2004; Ritchie et al., 2015). The use of the EB
method allows combination of information across genes thus improving variance estima-
tion.
Let xij be the expression level for the i
th gene from the jth sample and yj be the
covariate for the jth sample. The linear model of analysis can be expressed as
xij = βi0 + βi1yj + εij, i = 1, 2, ..., G, j = 1, 2, .., n. (2.13)
Assume that
E(xi) = Y βi, (2.14)
and
V ar(xi) = Wiσ
2
i , (2.15)
where xi = (xi1, xi2, ..., xin)
T , Y is a known design matrix and Wi is a known non-negative
definite weight matrix. Certain contrasts are assumed to be of biological interest and are
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where C is a known contrast matrix. For each gene i, a linear model is fitted to obtain
the coefficient estimator β̂i and the variance estimator s
2
i . Estimated covariance matrices
are given as V ar(β̂i) = Vis
2
i , where Vi is a positive definite matrix not depending on
s2i . The contrast estimator α̂i is given as α̂i = C
T β̂i with estimated covariance matrices
V ar(α̂i) = C
TViCs
2
i . Prior information is assumed on σ
2
i equivalent to a prior estimator






This describes how the variances are expected to vary across genes (Smyth, 2004). Using
Bayes’ rule, the posterior variance becomes a combination of an estimate obtained from











where d0 and di are prior and empirical degrees of freedom. The posterior values shrink
the observed variances towards the prior values with the degree of shrinkage depending on








where vij is the j
th diagonal element of CTViC.
To asses the significance of each gene, the moderated t-statistics and their associated
p-values are generally used (Ritchie et al., 2015). limma calculates the Bayesian log-
odds of differential expression for each gene. The higher the value of the log-odds, the
more significant the result. The family-wise error rate (FWER) and the FDR are used
in multiple testing adjustment. The LIMMA method is implemented in the R package
called limma.
2.2.3 Lassoed Principal Components (LPC)
The lassoed principal components (LPC) method involves using existing gene-specific
scores (T ) to calculate scores that provide a more accurate ranking of genes as differ-
entially expressed (Witten and Tibshirani, 2008). Some of the gene-specific scores can
be calculated using LIMMA (Smyth, 2005), SAM (Tusher et al., 2001) and standard-
ized regression methods, among others existing methods. LPC identifies significant genes
16
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based on the values of the FDRs. It estimates its FDR based on an adjustment of the
FDR of the T (Witten and Tibshirani, 2008). The LPC method does not assume that
genes are independent but rather takes into account that they work in pathways. The
LPC method is similar to the LIMMA method in that they both combine information,
or borrow strength, across genes. They do not also do permutation-based inference.
Let X be an n × G matrix of log-transformed gene expression levels, where n is the
number of samples and G is the number of genes. Also, let xi be the expression profile
for gene i and y be the vector of quantitative outcomes. A gene-specific score, ti, is









A small constant σ is added to the denominator of the gene score in order to avoid a
large ratio resulting from a small estimated standard deviation (Witten and Tibshirani,
2008).
To calculate the LPC scores, a model




is fitted, where ti is the gene-specific score calculated using standardised regression
method as in (2.20), βi is the multiple linear regression coefficient and vi is the eige-
narray of xi. The LPC score is the fitted value t̂i obtained from model (2.21). The LPC
approach can also be applied to studies with different outcome variables (e.g survival
outcome, two-class or multiple-class type of outcomes).
The LPC algorithm is implemented in both the R package called lpc (Witten and
Tibshirani, 2008) and BRB-ArrayTools (Simon et al., 2007).
2.2.4 Quantitative Trait Analysis (QTA)
This approach finds genes that are significantly correlated with a quantitative outcome
such as age. It uses the Pearson’s correlation or the Spearman’s (rank) correlation coef-
ficient as a measure of dependence to compute p-values.
Let Xij be the expression level for the i
th gene from the jth sample and yj be the
covariate for the jth sample. The (linear) model of analysis can be expressed as
Xij = βi0 + βi1yj + εij, i = 1, 2, ..., G, j = 1, 2, .., n. (2.22)
17
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Here, we assume that
εij ∼ N(0, σ2i ), i = 1, ..., G, j = 1, ..., n (2.23)
and that the yj values are fixed (not random). βi0 and βi1 represent the regression
coefficients specific to gene i. For testing the significance of correlation for the i-th gene





where SE(β̂i1) is the standard error of β̂i1. Ti has the t-distribution with n − 2 degrees
of freedom. We reject H0i if | ti |< tα/2, 0 < α < 1. Equivalently, one can test for ρi,
the correlation coefficient. Let xi = (xi1, xi2, ..., xin)
′ and y = (y1, y2, ...yn)
′. Given the
observations (xij, yj), the Pearson’s correlation coefficient for the i



































which also has a t-distribution with n − 2 degrees of freedom. Here ri is the estimator
of ρi. H0i is rejected if | t∗i |< tα/2, 0 < α < 1. With a simple algebraic manipulation,
it can be shown that (2.24) and (2.26) are equivalent and so the latter was employed in
this study.
There are two ways of controlling the number of false discoveries in the QTA ap-
proach. The first one is based on the p-values computed from the parametric t− or
F−tests. Here, a stringent p-value threshold (say p < 0.001), is used in controlling the
number of false discoveries. The second approach uses multivariate permutation tests
(Korn et al., 2004). The multivariate permutation tests are based on permutations of
the covariate. For each permutation, the parametric test statistics are re-computed to
determine a p-value for each gene. The genes are ordered by their p-values computed for
each permutation, with genes having the smallest p-values appearing at the top of the
list. For a pre-selected p-value threshold, the distribution of the number of genes that
would have p-values smaller than that threshold is computed. That is the distribution of
the number of false discoveries, since genes that are significant for random permutations
are false discoveries. The algorithm selects a threshold p-value so that the number of false
18
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discoveries is not greater than that specified by the user C percent (C%) of the time,
where C denotes the desired confidence level (Simon et al., 2007).
The QTA approach estimates false discovery rate (FDR) using the Benjamini and
Horchberg’s approach Benjamini and Hochberg (1995). For the ith gene, the estimated





where pi is the univariate p-value for the i-th most significant gene and G is the number
of gene tested.
A concise summary of the four statistical methods is provided in Table 2.1.
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2.3 Simulated Gene Expression Data
We conducted a simple simulation study to compare the four methods in terms of power.
Let n and G denote the number of samples and genes, respectively. Further, let D denote
the number of genes assumed to be truly differentially expressed. Then (G − D) genes
are assumed to be non-differentially expressed. The gene expression data matrix, X, is
a G × n matrix of log2-ratios. We can write X as X = (X1,X2), where X1 and X2
are D × n and (G − D) × n matrices, respectively. We set D = 50, and n = 35 and G
to be 1000. We generated the (1000 −D) genes from the standard normal distribution.
To generate the D genes, we used the standard normal distribution in conjunction with
the Cholesky decomposition Golub and Van Loan (1996) of their correlation matrix as
follows:
1. We generate an unstructured correlation matrix Ω. Ω is a (D+1)× (D+1) matrix
that has (i, j)th element given by ωi,j = corr(xi, xj)
2. Find the Cholesky factor, A, of Ω such that Ω = AA′.
3. Let zi ∼ N(0, In), i = 1, 2, ..., (D + 1).
4. Z = (z1, z2, ..., zD+1)
′
5. XD+1 = AZ.
XD+1 is the gene expression matrix for D genes that are assumed to be differentially
expressed or significantly correlated with the covariate y. y can take any of the D + 1
row vectors from the matrix XD+1. X1 is therefore a submatrix of XD+1 with dimensions
D × n. This simulation set-up assumes that each gene is observed across each sample.
An R code for the above simulation is available in the Appendix B.
All the four methods are applied to the simulated data. Differentially expressed genes
are identified based on the methods’ estimated FDR values. A gene is differentially
expressed if its estimated FDR is less than a pre-specified value α. Power is calculated as
the ratio of the number of correctly identified differentially expressed genes, true positives
(TP), to the total number of truly differentially expressed genes (Owzar et al., 2007).
2.4 Application
An analysis on a real microarray dataset is performed to evaluate how the methods
perform in a real situation. The four methods are applied to the melanoma cell lines
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dataset to identify DEGs. The genelists generated by the four methods are then applied to
an independent melanoma dataset for prognostic assessments. Below are the descriptions
of the datasets used in the application.
2.4.1 Data
Melanoma Cell Lines Dataset
The gene expression data (raw intensities) consists of 54 cell-lines (35 melanoma cell
lines and 19 normal human melanocytes (NHMs)), each with 45,015 probes. This data
is publicly available from Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/
geo/) under accession number GSE40047. Only the melanoma cell lines are analyzed.
The raw dataset is median-normalized and log2 transformed. If multiple probes map
to the same gene symbol, they are reduced to one per gene symbol by using the most
variable probe(set) measured by interquartile range (IQR) across arrays. Filtration and
normalization of the gene expression data is implemented using BRB-ArrayTools software
(Simon et al., 2007). A gene is filtered out if less than 20% of its expression data values
has at least 1.5-fold change in either direction from the genes median value. Genes with
more than 50 % missing data across all its samples are also filtered out. There are 3,860
genes available for subsequent analysis.
G2 Checkpoint Function
Having obtained the gene expression data, we need to quantify the biological process
in melanoma progression. We select the G2 checkpoint function in this regard. The
G2 checkpoint is a position of control in the cell cycle that delays or arrests mitosis
when DNA damage by radiation is detected. The G2 checkpoint prevents cells with
damaged DNA cell from entering mitosis, thereby providing the opportunity for repair
and stopping the proliferation of damaged cells. Figure 4.1 below shows the four phases
of the cell cycle, including the location of the G2 checkpoint as the last checkpoint before
mitosis. The G2 checkpoint function scores were obtained from Kaufmann’s lab (UNC
- Pathology and Lab Medicine) and had been calculated as ratios of mitotic cells in 1.5
Gy ironizing radiation (IR)-treated cultures in comparison to their sham-treated control
(i.e. IR to sham ratio) (Kaufmann et al., 2008). It had been shown in Omolo et al.Omolo
et al. (2013) that the G2 gene signature was prognostic for the development of distant
metastasis, hence the choice of G2 checkpoint function for this study.
Independent Melanoma Dataset
An independent dataset, consisting of gene expression data from 6307 genes on 58
22
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Figure 2.1: Cell cycle. After completing DNA synthesis and progression through the
G2 phase, the cell enters the mitotic phase, where the chromosomes segregate into two
daughter cells. Image downloaded from http://www.bristol.k12.ct.us/page.cfm?p=
7093.
primary melanomas with survival outcome, is obtained for assessing prognosis of the
gene signatures from the four methods. This data set has been reported in Winnepen-
ninckx et al. (2006) and will hereafter be referred to as the Winnx dataset. This data is
publicly available in the Array Express data repository at the European Bioinformatics
Institute (http://www.ebi.ac.uk/arrayexpress/) under the accession numbers: E-TABM-
1 IGR MELANOMA STUDY. The primary endpoint for the study was a 4-year distant
metastasis-free survival (DMFS), which was defined as the time interval between the
diagnosis of the primary cutaneous melanoma and a distant metastasis or death from
melanoma within 4 years. Patients alive at the date of last follow-up were censored
at that date. Patients were also separated into two groups, one group with distant
metastasis-free survival of more than 4 years (group M-) and one group with distant
metastasis-free survival of 4 years or less (group M+).
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2.4.2 List of DEGs
To find DEGs, we apply different software for different methods. For the LIMMA ap-
proach, we use limma R package. We fix the degrees of freedom for the design matrix to
be 5. For the SAM approach, the samr R package is used. ∆ is fixed at 0.00, to allow
a large list of DEGs to be generated at different estimated FDR values. The number of
nearest neighbors to use for imputation of missing features (knn.neighbors) is set at 10
and the number of permutations is fixed at 1000. The QTA method assesses significance
of correlation based on Spearman’s correlations and implements the procedure using the
BRB-ArrayTools software. Similarly, the LPC method is implemented by the BRB-
ArrayTools software. The number of DEGs are generated at various levels of estimated
FDR threshold (0.01, 0.05 ,0.1, 0.2) for all the methods.
2.4.3 Prediction and Prognosis
We assess the predictive quality of each of the genelists by its mean squared error (MSE)
of prediction of the G2 checkpoint function. For this, linear models containing significant
genes are formulated. Since G >> n, the least absolute shrinkage and selection operator
(LASSO) algorithm (Tibshirani, 1996) is used to select genes to include in the models.
LASSO builds a sequence of models containing upto n genes and index by F , the number
of algorithmic steps relative to the model containing n genes (full model). For each F , a
cross-validation estimate is obtained using the leave-one-out cross-validation (LOOCV)
method. The final model selected corresponds to the F -value with the minimal estimated
mean squared error.
We perform a survival risk prediction (SRP) to assess the clinical significance of the
genelists using the Winnx dataset. The clinical outcome for this dataset was 4-year
distant metastasis-free survival (DMFS) and the objective was to predict a patient’s risk
(low/high) for developing distant metastasis within 4 years of primary diagnosis. The
SRP procedure entails first reducing the number of candidate genes to only the Cox ones,
using the supervised principal component (SPC) method of Bair and Tibshirani (2004).
These Cox genes are then used to compute the prognostic index for each sample. Samples
(patients) with a prognostic index above the median are classified as high risk; otherwise,
they are low risk. A log-rank test is performed to test if the two survival curves for the
low- and the high-risk groups are significantly different, using the original DMFS values.
A genelist would be prognostic for DMFS if the log-rank test is significant. The entire
SRP procedure is implemented by a tool of the same name in BRB-ArrayTools software
(Simon et al., 2007). We compare the performance of the genelists produced by the four
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methods in survival risk prediction for the 58 samples in the Winnx dataset.
In addition, we use the Prediction Analysis of Microarrays (PAM) tool to predict the
group membership of the 58 samples. Samples were grouped into two classes: a group
with distant metastasis-free survival of more than 4 years (group M-) and a group with
distant metastasis-free survival of 4 years or less (group M+). PAM uses the shrunken
centroid algorithm developed by Tibshirani et al. (2002). This algorithm builds a number
of linear models and selects the model with the least prediction error. A cross-validation
estimate is obtained by using leave-one-out cross-validation (LOOCV). The entire model
building process is repeated for each leave-one-out training set. The misclassification rate
is calculated as the proportion of times the models incorrectly predict the class of the
excluded samples. The genelist with the lowest misclassification rate is considered a good
list for predicting a sample as belonging to group M+ or M-.
2.5 Results and Discussion
2.5.1 Differentially Expressed Genes
Each of the four methods is applied to the simulated data. The total number of genes
that are correctly identified as differentially expressed, true positives (TP), are recorded
at different estimated FDR levels. With the known number of TP, the power is also
calculated to aid in comparison. Table 2.2 shows the number of DEGs and power by
different methods at different FDR levels. The LPC method turns out to be the least
powerful of all the methods. The SAM and the QTA methods are the most powerful
methods in the identification of DEGs. The LIMMA method has moderate power (> 0.7)
for the FDR thresholds considered, except at the FDR < 0.01.
Although the SAM and the QTA methods performed the best with the simulated
dataset, we need to determine how they behave with a real dataset. We apply the
methods to the melanoma cell lines dataset (in 2.4.1). The results are different from the
ones obtained using the simulated dataset. We observe that while the QTA method did
well with the simulated dataset, its performance is the worst in the identification of DEGs
using the real dataset. In terms of power, the SAM method is still the best followed by
the LIMMA method.
The difference in the performance of the QTA method when applied to the simulated
and the real datasets could be explained by the fact that the simulated dataset is gen-
erated from a standard normal distribution. The QTA method strongly assumes that
the gene expression levels (log2-ratios) are normally distributed. Gene expression data
may violate this assumption. The LPC method assumes that a large set of genes work
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Table 2.2: Number of DEGs generated by the SAM, LIMMA, LPC and QTA methods at
different levels of estimated FDR.
Simulated dataset Melanoma dataset
Estimated FDR (α) SAM LIMMA LPC QTA SAM LIMMA LPC QTA
0.01 49 (0.98) 6 (0.12) 0 (0.00) 50(1.00) 0 8 3 0
0.05 52 (1.00) 39 (0.74) 0 (0.00) 51(1.00) 33 16 4 0
0.1 53 (1.00) 50 (0.88) 0 (0.00) 54 (1.00) 33 22 7 4
0.2 56 (1.00) 57 (0.82) 0 (0.00) 67 (1.00) 173 55 24 56
together in a pathway to cause an outcome. In cases where this assumption is not met
i.e. when only one gene or very few genes causes the outcomes, the LPC method loses
power in selecting significant genes. This could explain the low performance of the LPC
method in both simulated and real datasets. One disadvantage of the LPC method is that
it does not rank genes using a metric that is relevant or truly of interest. It rather finds
genes that generate high values when standard scores are projected into a high-variance
subspace of the gene expression data (Witten and Tibshirani, 2008).
Since different spots on the microarrays are assumed to contain different probes (in the
case of cDNA arrays) or different oligos (in the case of high-density oligonucleotide arrays),
the expression of genes are assumed independent on these spots, even though some probes
may represent the same gene and have dependent expression profiles. Consequently,
not all the methods for selecting DEGs assume that the genes are independent. In
particular, the LPC method does not assume that the genes are independent, while the
SAM and the QTA methods do assume independence. While the LIMMA approach
assumes independence, it works well when the genes are assumed dependent as well
(Smyth, 2004). This has been one of the main differences among the four methods.
Before analyzing the validation datasets, the gene expression data were filtered and
normalized to eliminate genes that were not sufficiently differentially across the samples
and to correct for sample-specific bias (due to experimental artefacts/errors) and render
the samples comparable, respectively. After normalization, the resulting expression data
was log2-transformed so as to achieve a symmetric error distribution. Figure 2.2 shows
the error distribution for four randomly selected melanoma cell lines and primary tumors
as symmetric and can be regarded as “approximately” normal.
Figure 2.3 shows the number of overlapping genes from the four methods. It is very
common to find a very low number of overlapping DEGs between multiple methods
(Jeffery et al., 2006; Andrew et al., 2015).
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Figure 2.2: Error distribution for four of the melanoma cell lines (A) and primary tumors
(B). The histograms are fairly symmetric and would approximate the normal distribu-
tions, considering the number of genes in each dataset.
Figure 2.3: Number of overlapping genes from the SAM, the LIMMA, the LPC and the
QTA genelists based on the melanoma cell lines dataset.
2.5.2 Prediction and Prognosis
We use the genelists generated by the four methods to build linear predictive models
for the G2 checkpoint function, via the LASSO with LOOCV. Table 2.3 is a summary
of the results. The QTA genelist turns out to be the best in predicting G2 followed by
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the SAM genelist, then the LIMMA genelist. In order to get additional insight into the
performance of the four methods, the four genelists are combined to get 52 unique genes.
This combined genelist yields an r2 of 0.5. A combination of all the genelists has a much
better performance than most of the genelists generated by the individual methods.
Table 2.3: Comparison of G2 checkpoint function prediction by the SAM, LIMMA, LPC
and QTA genelists generated at α = 0.1. The number of genes associated with DMFS
(Cox genes) are also included.
Method # Genes in model r p R2 Adjusted R2 # Cox genes
SAM 10 0.652 <0.001 0.43 0.193 5
LIMMA 6 0.550 0.0006 0.3 0.150 1
LPC 3 0.421 0.0117 0.18 0.100 1
QTA 4 0.721 <0.001 0.52 0.456 1
Combine 16 0.710 <0.001 0.5 0.105 6
Gene expression data for the four genelists are extracted from the Winnx dataset for
performing survival risk prediction. The difference between the survival curves for the
low- and high-risk groups is significant for the SAM genelist (log-rank χ2 = 5.5, P =
0.019), the LPC genelist (log-rank χ2 = 5.7, P = 0.0166) and the QTA genelist (log-rank
χ2 = 4.8, P = 0.0374) but not for the LIMMA genelist (log-rank χ2 = 0.1, P = 0.791).
Results are shown in Figure 2.4.
We further subjected the combined genelist to a survival risk prediction analysis
using the Winnix dataset. This genelist provides a good prediction of the G2 checkpoint
function and is the most prognostic genelist (log-rank χ2 = 8.5, P= 0.00351, Fig 2.5).
We also observe that the misclassification rates based on PAM analysis are high for all
the genelists. The misclassification rates are as follows: 36%, 41%, 31% and 36% for the
SAM, LIMMA, LPC and QTA methods respectively (Tab 2.4).
Table 2.4: Misclassification rates based on the Prediction Analysis for Microarrays
(PAM).
SAM LIMMA LPC QTA
Misclassificarion
rate
36% 41% 31% 36%
2.6 Conclusion
In this chapter, we compare four methods (SAM, LIMMA, LPC and QTA) for identifying
DEGs in terms of their power to detect differential gene expression, the predictive ability
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Figure 2.4: Survival curves for the low and high risk groups A: The survival curve
generated by the SAM genelist, B: The survival curve generated by the LIMMA genelist,
C: The survival curve generated by the LPC genelist and D: The survival curve generated
by the QTA genelist.
of the genelists for a continuous outcome, and the prognostic properties of the genelists for
DMFS. One simulated dataset and two publicly available datasets from melanoma studies
are used in this regard. Results show that the selection of the DEGs heavily depends on
the choice of the gene selection method. This may be due to the assumptions made by
different methods. The LIMMA method assumes that the null distribution of the test
statistics is the same for all genes. The QTA approach depends heavily on the normality
and linearity assumptions, and the SAM method, in case of two groups scenario, assumes
equal variance. Therefore, to obtain reliable results for detecting significant genes in
microarray data analysis, we need to explore the characteristics of the data and then
apply the most appropriate method under the given situation. Table 2.5 and 2.6 list the
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Figure 2.5: Survival curve for the low and high risk groups generated by the combined
genelist containing 52 unique genes.
merits and the demerits of the four methods evaluated in this chapter.
In addition to finding DEGs, it is also important to assess the biological and clinical
importance of these genelists. One way of doing this is by identifying gene signatures
that are better predictors of a quantitative outcome or a patient’s survival. This may
help in tailoring therapeutic strategies to a single patient rather than the one-size-fits-
all paradigm. Results from this chapter’s work has shown that a combined genelists is
more accurate in separating melanoma patients into high/low risk groups for developing
distant metastasis. While the SAM approach was more powerful in terms of the number of
significant genes detected using real dataset, the genelist generated by the QTA approach
performed better in terms of prediction. Therefore, the QTA method would be preferred
over the other approaches in predicting a quantitative outcome.
Omolo et al. (2013) employed the QTA method (together with a Bayesian proce-
dure) to identify 165 genes that were associated with the G2 checkpoint function in
melanoma lines. Some of these genes were found to be expressed differentially in wild-
type (WT), NRAS-mutant and BRAF-mutant melanoma lines, through RNA expression
analysis. This 165-list was also prognostic for distant metastasis-free survival in primary
melanomas. Our SAM-list (n = 33), LIMMA-list (n = 22), LPC-list (n = 7) and QTA-
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list (n = 4) had ten (10), three (3), three (3) and one (1) genes in common with the 165
gene list, respectively. Kaufmann et al. (2014) showed that some of the genes correlated
with chromosomal instability (n = 190), obtained using the QTA and a Bayesian method,
were linked to amplification or deletion of the gene, e.g. DDR2. Our SAM-list and the
LIMMA-list had two (2) genes each in common with the 190-list, which included DDR2.
Thus, some of the DEGs by the proposed statistical methods in this manuscript have
been biologically validated to be true positives (TP) in recent studies.
Heterogeneity of the results in this chapter motivates the development of better meth-
ods that are more robust. In the next chapter, we will develop an alternative method, that
is based on copula models, for finding differentially expressed genes when the outcome of
interest is quantitative in nature.
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To appreciate the application of copulas to differential gene expression analysis, a ba-
sic understanding of copula theory is essential. This chapter introduces the concept of
copulas, their properties and families. Methods of estimating copula parameters are also
discussed in detail.
3.1 Introduction to Copulas
Theorem (Sklar 1959). Let F be an m-dimensional distribution function with margins
F1, F2, ..., Fm . Then there exists an m-copula C such that for all x in R̄m,
F (x1, x2, ..., xm) = C(F1(x1), F2(x2), ..., Fm(xm)). (3.1)
If F1, F2, ..., Fm are all continuous, then C is unique; otherwise, C is uniquely determined
on Ran F1×Ran F2×, ...,×Ran Fm . Conversely, if C is an m-copula and F1, F2, ..., Fm
are distribution functions, then the function H defined by (3.1) is an m-dimensional
distribution function with margins F1, F2, ..., Fm.
Thus, a copula is a multivariate distribution on the m-dimensional unit cube, [0, 1]m,
with uniform marginals.
3.1.1 Probabilistic Interpretation of Copula Function
From the Sklar’s theorem, copulas are joint distribution functions of standard uniform
random variates:
C(u1, ..., um) = Pr(U1 ≤ u1, ..., Um ≤ um), (3.2)
for any u = (u1, ..., um)
′ ∈ [0, 1]m. We know that the probability integral transform of
random variable Xi → Fi(xi), is distributed as standard uniform Ui, i = 1, ...,m, that is,
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Fi(xi) ∼ Ui . Then
C(F1(x1), ..., Fm(xm)) = Pr{U1 ≤ F1(x1), ..., Um ≤ Fm(xm)}
= Pr{F−11 (U1) ≤ x1, ..., F−1m (Um) ≤ xm}
= Pr{X1 ≤ x1, ..., Xm ≤ xm}
= F (x1, ..., xm). (3.3)
3.2 Classes of Copulas
The commonly used classes of copula are the Archimedean and elliptical copulas (Yan,
2007). Figure 3.1 shows the scatter plots for 2000 samples generated from four differ-
ent copulas namely: the Normal copula, the Frank copula, the Gumbel copula, and the
Clayton copula. The standardized correlation matrix is used to determine the depen-
dence structure of a copula since copulas are invariant to monotonic transformation of
the margins. Some of the commonly used dispersion structures are: exchangeable (ex),
Toeplitz (toep), autoregressive of order 1 (ar1), and unstructured (un). Correlation ma-
trices corresponding to the mentioned structures are as follows for the case of m = 3
(Yan, 2007): 1 ρ1 ρ1ρ1 1 ρ1
ρ1 ρ1 1
 ,
 1 ρ1 ρ2ρ1 1 ρ1
ρ2 ρ1 1
 ,











The simplest copula function is the product copula that has the following form
C(u1, u2) = u1u2, (3.5)
where u1 and u2 are uniformly distributed over [0,1]. This copula corresponds to the
independence case.
3.2.2 Archimedean Copulas
These types of copulas are common in applications because they are easy to construct and
a great variety of copulas belong to this class. These copulas also posses nice properties
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Figure 3.1: Scatter plots of 2000 random samples generated from the bivariate (a) Normal
copula, (b) Frank copula, (c) Gumbel copula and (d) Clayton copula.
for example, most but not all extend to higher dimensions via the associativity property
(Nelsen, 2006).
Definition: C is a bivariate Archimedean copula if it can be presented as
C(u, v) = ψ−1[ψ(u) + ψ(v)], (3.6)
where ψ is a continuous, strictly decreasing, convex function from [0, 1] to [0,∞] such
that ψ(1) = 0. The function ψ is called the generator function of the copula. The pseudo-




ψ−1(t) if 0 ≤ t ≤ ψ(0)
0 if ψ(0) ≤ t ≤ ∞
Table 3.1 highlights some of the commonly used bivariate Archimedean copulas with
corresponding parameter ranges and generators. In the Clayton copula, the margins
become independent as θ approaches zero. The downside of this copula is that it cannot
account for a negative dependence. Likewise, the Frank copula attains independence as
θ reaches zero. The Frank copula is symmetric in both tails. It is very popular because
it can account for both negative and positive dependence. Just like the Clayton copula,
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the Gumbel copula does not account for negative dependence.
Table 3.1: Archimedean copulas and their generators
Copulas c(u1, u2; θ) Parameter θ range Generator
Clayton (u−θ1 + u
−θ











Gumbel exp{−[(−ln u1)θ + (−ln u2)θ]1/θ} [1,∞) (−ln t)θ
There are many different copula functions belonging to the Archimedean family and
a lot of different families or classes of copula functions but they are not commonly used
in practical applications because of their analytical complexity. Nelsen (2006) gives an
extensive review of these copulas.
3.2.3 Elliptical Copulas
An elliptical copula is the copula corresponding to an elliptical distribution. A general
discussion about the elliptical distributions can be found in Fang et al. (1990). Let F
be the multivariate cumulative distribution function (CDF) of an elliptical distribution.
Let Fi be the CDF of the i
th marginal density and F−1i be its inverse function (quantile
function), i = 1, ...,m. The elliptical copula determined by F is
C(u1, ..., um) = F [F
−1
1 (u1), ..., F
−1
m (um)]. (3.7)
Two copulas belong to this family: The Gaussian and the student t-copula
The Gaussian copulas: A bivariate normal copula is expressed as

































denotes the univariate standardized distribution function. A normal copula allows for
equal degrees of positive and negative dependence. This makes it flexible in applications.
This study adopts this copula in most of its analysis.
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where t−1θ1 (u1) is the inverse of the CDF of standard univariate student-t distribution with
θ1 degree of freedom. θ1 controls the heaviness of the tails. As θ1 → ∞, the student-t
copula behaves like the Gaussian copula.
3.3 Estimation of Copula Functions
This section describes different approaches for estimating copula functions. Given a cop-
ula density function, one can fit a copula model by estimating its parameters. A number
of methods have been proposed in the literature. Most of the estimation methods pro-
posed in the literature (Yan, 2007) are likelihood-based and include the exact maximum
likelihood methods (EML), the inference for margins approach (IFM) and the canoni-
cal maximum likelihood estimation approach (CMLE). IFM and CMLE are also called
multistage estimation methods. Like in any estimation problem, a model needs to be
specified. The model of interest for all the above mentioned estimation approaches is
expressed as
F (x1, x2, ..., xm) = C(F1(x1), F2(x2), ..., Fm(xm)), (3.12)
where F is a continuous marginal with density f .
Model (3.12) may either be a parametric or semi-parametric model, depending on
whether assumptions are made on the marginal distribution F or not. It is a fully
parametric model if distribution assumption is made on the marginals. The estimation of
parametric models relies on the assumption of parametric univariate maginal distribution.
The success of estimating a parametric model depends on using an appropriate marginal
distribution. Finding an appropriate marginal distribution is always not straight forward
especially if the marginals show evidence of heavy tails and skewness. In semi-parametric
models, no assumption is made on the marginals but the dependence structures, which
in copulas, is assumed to come from some parametric family.
3.3.1 Copula density and likelihood function
From Sklar’s theorem
F (x1, x2, ..., xm) = C(F1(x1), F2(x2), ..., Fm(xm)), (3.13)
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for (x1, ..., xm) in support of F . Upon differentiation, (3.13) becomes











Here, f , c and fi are the densities for F , C and Fi, i = 1, 2, ...,m, respectively. Now, con-













where Ln is the likelihood function. In practice, it is more convenient to work with
the logarithm of the likelihood function because it simplifies subsequent mathematical
analyses. Since the logarithm is monotonically increasing function, maximizing the log of
a function is the same as maximizing the function itself. The log-likelihood representation










3.3.2 Exact Maximum Likelihood Estimation Method
This approach estimates the copula parameter and the parameters of uncorrelated mar-
gins simultaneously. The estimation of marginals affects the estimation of the copula,
and vice versa. The computation will also be of concern if both copula and marginals
take some complicated form. The number of parameters to be estimated simultaneously
can be large hence a computational burden.
Consider a copula-based parametric model for the random vector X, with cumulative
distribution function
F (x1, x2, ..., xm;β1,β2, ...,βm) = C(F1(x1;β1), F2(x2;β2), ..., Fm(xm;βm);ρ), (3.17)
where Fi, ..., Fm are univariate cumulative distribution functions with respective param-
eters β1, ...,βm, and C is a family of copulas parametrized by a vector of parameters ρ.
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where θ̂EML = (β̂, ρ̂), ρ̂ denotes a vector of estimates for the copula parameters, and
β̂ denotes a vector of estimates for the parameters of the marginal distributions. We
assume that the usual regularity conditions (Shao, 2003; Serfling, 2002) for asymptotic
maximum likelihood theory hold for the multivariate model (that is the copula) as well
as for all of its margins (the univariate probability density functions). Under the usual
regularity conditions, the maximum likelihood estimator is asymptotically multivariate
normal;
√
n(θ̂EML − θ0)→ N(0,F−(θ0)). (3.20)
F−(θ0) is the Fisher’s information matrix and θ0 is the true value. The covariance matrix
of θ̂EML (Fisher’s information matrix) may be estimated by the inverse of the negative
Hessian matrix of the likelihood function.
3.3.3 Inference Function for Margins Method
This method was proposed in a general framework in Xu (1996) and is discussed for
copula in Joe (2005). It is motivated by the fact that EML estimation approach is
computationally intensive as the number of parameters to be estimated increases.
In this approach, the log-likelihood function is maximized in two stages. In the first
stage, the i = 1, ...,m log-likelihood functions of the margins are optimized to obtain the





The vector of the copula parameters are then estimated in the second stage using the





log c(F1(x1j; β̂1), ..., Fm(xmj; β̂m);θ). (3.22)
The efficiency of this approach was studied in Joe (2005). Under regular conditions,
θ̂IFM is asymptotically normal;
√
n(θ̂IFM − θ0)→ N(0,G−(θ0)), (3.23)
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where G−(θ0) is the Godambe information matrix. This approach yields parameters that
are less efficient in the presence of strong association than the EML approach though the
loss of efficiency is not great (Joe, 2005).
3.3.4 Canonical Maximum Likelihood Estimation(CMLE) Method
In this approach, no parametric assumptions are made on the marginals and therefore, it
relies on the concept of empirical marginal transformation. The transformation approx-









I (Xij ≤ xi) , (3.24)
where I is the indicator function. Rescaling the empirical distribution by n
n+1
avoids the
potential unboundedness of log(c(F1(x1j), ..., Fm(xmj);θ) as some of the Fi(xij)’s tend to
be one (Genest et al., 1995). These empirical CDFs are then used in (3.15) to estimate





log c(F̂1(x1j), ..., F̂m(xmj);θ) (3.25)
Under suitable regularity conditions, θ̂CML is consistent and is asymptotically normal
Genest et al. (1995).
3.4 Copula-based Dependence Measure
In this section, the two most widely known scale-invariant measures of association, both
of which measure a form of concordance, are briefly described. These are the population
Kendall’s tau and the Spearman’s rho. Other existing measures of concordance are Gini’s
gamma and Blomqvist’s beta.
3.4.1 Concordance
Let (xi, yi) and (xj, yj) denote two observations from a vector (X, Y ) of continuous ran-
dom variables. We say that (xi, yi) and (xj, yj) are concordant if xi < xj and yi < yj , or
if xi > xj and yi > yj. Similarly, we say that (xi, yi) and (xj, yj) are discordant if xi < xj
and yi > yj or if xi > xj and yi < yj . Alternatively, (xi, yi) and (xj, yj) are concordant
if (xi − xj)(yi − yj) > 0 and discordant if (xi − xj)(yi − yj) < 0 (Nelsen, 2006).
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3.4.2 Kendall’s Tau
The definition of Kendall’s tau as highlighted in Nelsen (2006) is as follows.
Let (X1, Y1) and (X2, Y2) be independent and identically distributed random vectors
each with joint distribution function H. Kendall’s tau is defined as the difference between
the probabilities of concordance and discordance:
τX,Y = Pr[(X1 −X2)(Y1 − Y2) > 0]− Pr[(X1 −X2)(Y1 − Y2) < 0] (3.26)
This can be expressed in terms of Copula as follows





C(u, v)dC(u, v)− 1 (3.27)
where C is the copula associated to (X, Y ).
3.4.3 Spearman’s Rho
This measure is also based on concordance and discordance. To obtain this measure, we
let (X1, Y1), (X2, Y2) and (X3, Y3) be three independent random vectors with a common
joint distribution function H whose margins are F and G and copula C. Spearman’s rho
is the probability of concordance minus the probability of discordance for two vectors
(X1, Y1), (X2, Y3) (Nelsen, 2006) and it is expressed as
ρX,Y = 3(Pr[(X1 −X2)(Y1 − Y3) > 0]− Pr[(X1 −X2)(Y1 − Y3) < 0]) (3.28)
The pair (X3, Y2) could be used as well. We note that while the joint distribution function
of (X1, Y1) is H(x, y), the joint distribution function of (X2, Y3) is F (x)G(y) because X2
and Y3 are independent.
In terms of copulas, (3.28) can be expressed as





(C(u, v)dudv − 3. (3.29)
Equation (3.29) can also be expressed as





[C(u, v)− uv]dudv. (3.30)
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3.5 Choosing A Copula
There exists a wide range of copula families that are available for use. For detailed
coverage about copula families, see Nelsen (2006). This presents a challenge when it
comes to specification of a suitable copula for a given dataset.
Several tests have been proposed for the copula specification. The most commonly
used is the goodness-of-fit test (Fermanian, 2005; Wang, 2010; Genest et al., 2006; Dobri
and Schmid, 2007; Berg, 2009). Goodness-of-fit tests are based on a direct comparison of
the dependence implied by the copula with the dependence observed in the data.
In most empirical applications, the unique copula C is assumed to come from a para-
metric family C0 = {Cθ, θ ∈ Θ} with Θ ⊂ R . In goodness-of-fit testing for copula models,
the hypothesis of interest is given by H0 : C ⊂ C0 , i.e. that the copula C belongs to
a predetermined parametric family C0. For testing H0, the marginal distributions are
treated as nuisance parameters and are replaced by their empirical distribution functions
F̂i(xi) as defined in (3.24) Genest et al. (2009).
Copulas can also be selected according to their ranks based on some criteria. The
most commonly used are the Akaike’s Information Criteria (AIC) Akaike (1974) and the








ln[c(u1j, u2j); θ] +Kln(n). (3.32)
Here, uij = Fi(xij), i = 1, 2, and K = 1 for the one-parametric copulas. Similarly,
K = 2 for the two-parametric copulas. A copula with the least AIC or BIC is chosen to
be the best.
3.6 Application of Copula in Different Fields
Copula models have become popular modelling tools in many fields where the main
interest is in the dependence of marginal distribution. Copula methods have mainly
been applied in finance and actuarial science (Romano, 2002; Cherubini et al., 2004).
In bioinformatics, Owzar et al. (2007) used copulas to identify prognostic genes. Kim
et al. (2008) reconstructed gene networks from gene expression data using copulas. Bao
et al. (2009) described a semiparametric copula model via extended rank likelihood which
allows estimation of the dependence structure of multiple continuous variables, ordinal
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variables, or the mixture of those two types. Yuan et al. (2008) proposed a semiparametric
copula method for microarray-SNP genomewide association analysis using pedigree data.
They performed the gene copy family analysis using a multivariate normal copula. Li
et al. (2006) developed and implemented a copula variance-components (VC) method,
that directly models the nonnormal distribution using Gaussian copulas. Escarela and
Carrire (2003) proposed a fully parametric model for the analysis of competing risks data
where the types of failure may not be independent. They applied their copula method
to a prostate cancer data set. Copulas has also been applied in the energy sector. Louie
(2014) modeled wind power using Archimedean and Gaussian copula.
Copula methods have been widely applied in bioinformatics but their applications in
microarray data for gene selection is still limited (Owzar et al., 2007; Bao et al., 2009;
Emura and Chen, 2016). In the next chapter, we use the concept of copula models
discussed in this chapter to find DEGs when we have a quantitative outcome.
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Using Copulas to Select
Differentially Expressed Genes
In this chapter, we develop a copula-based algorithm for finding differentially expressed
genes. The copula-based algorithm so developed is evaluated using several simulation
datasets. It is then applied to a real dataset to identify prognostic genes. This chapter
is organised as follows: In section 4.1, we provide the motivation for the development of
the copula-based algorithm. In section 4.2, we develop an algorithm based on the copula
models for differential gene expression. Section 4.3, describes the simulation set up for
evaluating the copula-based approach and the application is described in section 4.4.
4.1 Motivation
Melanoma of the skin is among the most common cancer types in the United States.
It is the fifth and seventh most commonly diagnosed carcinoma in men and women,
respectively (Siegel et al., 2017). In Kenya, data on melanoma of the skin is not well doc-
umented. According to the information from HealthGrove (2017), the annual mortality
rate per 100,000 people from malignant skin melanoma in Kenya is 20%. A major chal-
lenge with melanoma is the identification of therapeutic targets. Multi-gene signatures
have shown promise in this regard and a number of these signatures have been developed
within the last decade (Winnepenninckx et al., 2006; Mandruzzato et al., 2006; John et al.,
2008; Bogunovic et al., 2009; Jönsson et al., 2010; Carson et al., 2012; Omolo et al., 2013;
Kaufmann et al., 2014). Winnepenninckx et al. (2006) identified 254 genes that were
associated with distant metastasis-free survival of patients with primary melanoma, of
which 174 correspond to known genes. Mandruzzato et al. (2006) identified 80 probes
that were correlated with overall survival in a cohort of patients with stage III and IV
melanoma, 30 of which were associated with survival. John et al. (2008) found 21 differ-
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entially expressed genes which showed ability to separate prognostic groups. Bogunovic
et al. (2009) identified a group of 266 genes which can predict survival in metastatic
melanoma. Jönsson et al. (2010) identified gene signatures that were associated with
four distinct subtypes of metastatic melanoma (immune response, pigmentation differ-
entiation, proliferation, and stromal composition genes). They found few common genes
between the Winnepenninckx et al. (2006) metastasis signature and their proliferative
subtype. Carson et al. (2012) identified 316 probes whose expression was correlated
with G1 checkpoint function in melanoma lines. When applied to microarray data from
primary melanomas, the 316 probe list was prognostic of 4-year distant metastasis-free
survival. Omolo et al. (2013) identified 165 genes that were correlated with G2 checkpoint
function, 32 of which were prognostic. The signature was enriched in lysosomal genes and
contained numerous genes that are associated with regulation of chromatin structure and
cell cycle progression. Kaufmann et al. (2014) generated a gene signature with 190 genes
which were correlated with chromosomal instability index (CIN). This gene signature was
however found not to be prognostic of metastasis-free survival.
The development of such gene signatures require use of statistical methods. Carson
et al. (2012); Omolo et al. (2013) and Kaufmann et al. (2014) used parametric methods
based on the t-test with multiple corrections. One advantage of these methods is they offer
a straightforward approach to calculating p-values and confidence intervals. Moreover, for
large samples, the distribution of the t-statistic is independent of the overall expression
level of the gene. Unfortunately, for small sample sizes, the t-test based methods depend
on strong parametric assumptions. These assumptions may be violated in practice, and so
non-parametric methods have also been applied in some studies (Mandruzzato et al., 2006;
Bogunovic et al., 2009; John et al., 2008). For these methods, the distribution of random
errors are estimated without strong parametric assumptions. The Significance analysis of
microarray (SAM) method (Tusher et al., 2001), in particular, avoids high variance that
results from estimating the variance of each gene separately. When sample size is small,
any method that reduces the variance in the estimates produce more accurate results.
The non-parametric methods also have disadvantages which vary from one method to the
other. For example, the Wilcoxson-test approach exhibits low power in the identification
of differentially expressed genes (Troyanskaya et al., 2002). For a detailed review of
methods for finding differentially expressed genes, see Troyanskaya et al. (2002); Bair
(2013); Bandyopadhyay et al. (2014); Chaba et al. (2017).
Despite all the proposed methods mentioned above, there is no unanimous agreement
on any particular gene selection method. Furthermore, most methods were developed
for finding differentially expressed genes based on groups or classes of samples (discrete
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covaiates). However, there are many outcomes of interest that are continuous in nature.
In this chapter, we propose an algorithm for selecting genes associated with a contin-
uous but non-clinical outcome based on a semi-parametric copula model. An advantage
of the copula-based approach is its compatibility with any distribution function. This
allows for the relaxation of the assumption of specific distribution. Owzar et al. (2007)
has applied a copula-based approach to identify genes that are differentially expressed
between stage I and III lung cancer patients based on survival copulas and family wise
error rate (FWER) control. In contrast, our proposed algorithm is based on a continuous
outcome from melanoma cell lines and controls for the false discovery rate (FDR), since
the FWER is often too conservative (Benjamini and Hochberg, 1995).
The performance of our copula-based approach in terms of power is assessed via
simulations. The method is then applied to a melanoma cell lines dataset to find genes
that are correlated with G2 checkpoint function. The gene signature generated by copula
approach is then subjected to an independent primary melanoma dataset to determine if
it is prognostic of 4-year distant metastasis-free survival in melanoma patients.
4.2 Copula Model for Differential Gene Expression
We are interested in the pairwise correlation between each gene’s expression profile and a
quantitative outcome. Therefore, the copula of interest is the bivariate copula (m = 2).
Suppose a microarray experiment consists of n subjects/samples and G genes. Let xi =
(x1i, ..., xni)
′
be a vector of gene expression profile for gene i and y = (y1, ..., yn)
′
be a
vector of the covariate of interest (quantitative trait). We wish to find K genes that are
correlated with Y , 0 < K < G. That is, we are interested in determining whether, for
each gene i, xi and y are independent or not. The test for independence, thus, becomes
testing for null hypothesis
H0i : Y ⊥ Xi (Xi and Y are independent) (4.1)
against the alternative hypothesis
H1i : Y 6⊥ Xi (Xi and Y are independent) (4.2)
The biological questions of differential gene expression in microarray consists of multiple
hypothesis testing problem in which several hypotheses are tested simultaneously. In this
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case, the hypothesis of interest becomes









In terms of copulas, assume that for each gene i, the joint distribution of Y and Xi is
generated by a parametric copula C(u1, u2; θi) such that
Hi(y, x) = C[F (y), Fi(x); θi], (4.5)
where Hi(y, x), F (y) and Fi(x) are the CDFs of (Y,Xi), Y and Xi respectively. Here






C(u1, u2; θi) = u1u2 for all (u1, u2)








C(u1, u2; θi) 6= u1u2 for some (u1, u2)T ∈ [0, 1]2
]
. (4.7)
A normal copula, for instance, attains independence when θi = 0. In this case, the




(θi = 0), vs.H1 :
G⋃
i=1
(θi 6= 0). (4.8)
4.2.1 Hypothesis Testing
We are testing (4.8), so G hypothesis tests are performed simultaneously. Each hypothesis
tests H0 : θ = 0. We need to estimate the distribution of θ̂i under the null hypothesis.
Rather than assuming a parametric distribution for the null hypothesis, a permutation
resampling based approach (Westfall and Young, 1993) can be used to find a gene-specific
p-value. For a given α, a gene is differentially expressed if its p-value < α. Since the
goal is to test several hypothesis simultaneously, it is crucial to employ a method that
accounts for multiplicity. The false discovery rate (FDR) (Storey and Tibshirani, 2003)
is used in this regard. The global null hypothesis (4.8) is rejected if at least one of its
components (H0i) is rejected, based on the estimated FDR values.
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4.2.2 Copula Algorithm for Identifying DEGs
Our copula-based algorithm for finding differentially expressed genes (DEGs) can be
summarised as follows:
1. Estimate θi using the CMLE method. In the CMLE approach, no assumption is
made on the marginal distribution. The marginal distribution for each gene, Fi(xi)
and a quantitative outcome, F (y), are replaced with their estimators F̂i(xi) and
(F̂ (y)), respectively, to obtain θ̂i.
θ̂i ≈ arg max
n∑
j=1
log c(F̂i(xi), F̂ (y); θ). (4.9)
A detailed explanation of the CMLE method is in Section 3.3.4.
2. Find gene-specific p-values (unadjusted p-values) using the permutation based re-
sampling method. Permutation approach provides an efficient method to testing
when data do not conform to the distribution assumptions. To compute unadjusted
p-value for each gene, we follow the procedure below.
(a) Permutate the quantitative outcome column B times as you hold the gene
expressions matrix fixed.
(b) For the bth permutation, b = 1...B, compute test statistics θ̂1b, ..., θ̂Gb for each
hypothesis using equation (4.9).
(c) After the B permutations are done, for two-sided alternative hypotheses, the
permutation p-value for hypothesis Hi is
pi =
#{b : |θ̂ib| ≥ |θ̂i|}
B
(4.10)
where θ̂i is the original θ̂ for the i
th gene before the permutation.
3. Apply the FDR approach to control for type I error. The procedure below outline
the steps followed in estimation of FDR given the p-value (Storey and Tibshirani,
2003).
(a) Let p(1) ≤ p(2) ≤ ... ≤ p(G) be the ordered p-values. This also denotes the
ordering of the features in terms of their evidence against the null hypothesis.
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(c) Let f̂ be the natural cubic spline with 3 df of π̂0(λ) on λ.
(d) Set the estimate of π0 to be π̂0 = f̂(1) .
(e) Calculate q̂(p(G)) = π̂0p(G).








(g) The estimated q-value for the ith most significant feature is q̂(p(i)).
4. A gene is differentially expressed if its estimated FDR (estimated q-value) is less
than some specified value α ∈ [0,1]
An R code for implementing the above algorithm is available in the Appendix C.
4.3 Simulated Gene Expression Data
Twelve simulation scenarios are considered in evaluating the performance of the proposed
copula method in terms of power. Let n and G denote the number of samples and genes,
respectively. Further, let D denote the number of genes assumed to be truly differentially
expressed. Then (G − D) genes are assumed to be non-differentially expressed. The
gene expression data matrix, X, is a G × n matrix of log2-ratios. We can write X as
X = (X1,X2), where X1 and X2 are D × n and (G − D) × n matrices, respectively.
We set D ∈ (50, 100, 200), n ∈ (20, 35, 50, 100) and G to be 1000. We generate the
(1000 − D) genes from the standard normal distribution. To generate the D genes, we
use the standard normal distribution in conjunction with the Cholesky decomposition
(Golub and Van Loan, 1996) of their correlation matrix as follows:
1. Generate an unstructured correlation matrix Ω. Ω is a (D + 1) × (D + 1) matrix
that has (i, j)th element given by ωi,j = corr(xi, xj)
2. Find the Cholesky factor, A, of Ω such that Ω = AA′.
3. Let zi ∼ N(0, In), i = 1, 2, ..., (D + 1).
4. Z = (z1, z2, ..., zD+1)
′
5. XD+1 = AZ
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XD+1 is the gene expression matrix for D genes assumed to be differentially expressed
and a covariate y. y can take any of the D+ 1 row vectors from the matrix XD+1. X1 is
therefore a submatrix of XD+1 with dimensions D × n. This simulation set-up assumes
that each gene is observed across each sample. The R code for the above simulation is
available in the Appendix B.
The developed copula method is applied to the 12 simulated datasets to evaluate its
power in identifying DEGs. We transpose X in the analysis, so that X′ has genes on the
columns and samples on the rows. We follow the procedure in section 4.2.2 to identify
DEGs at different estimated FDR values. A normal copula is assumed. See Appendix A
for description a normal copula. Power is calculated as the ratio of the number of correctly







We apply the developed copula-based algorithm to a publicly available melanoma data.
Gene expression profiles from the melanoma cell lines dataset with 3,860 genes and 35
samples is used. The G2 checkpoint function data is used as the quantitative trait data.
All these datasets are described in Chapter 2, Sub-Section 2.4.1.
A normal copula is assumed for the analysis of the melanoma dataset. Such an
assumption was made in the Owzar et al. (2007) for lung cancer. Genes that are cor-
related with the G2 checkpoint function are selected based on estimated FDR values.
The predictive quality of the copula genelist is assessed via the least absolute shrinkage
and selection operator (LASSO) algorithm (Tibshirani, 1996) with leave-one-out cross-
validation (LOOCV) method. To check the biological significance of the G2 signature
generated by the copula method, we use the independent dataset in Winnepenninckx
et al. (2006) (dataset described in Chapter 2, Section 2.4.1) to identify genes that could
predict a patient’s risk (low/high) for developing distant metastasis within 4 years of
primary diagnosis. The supervised principal component method (Bair and Tibshirani,
2004) is used to separate the samples into high/low risk group. This procedure was
implemented in the BRB-ArrayTools software.
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4.5 Results and Discussion
Heatmaps of the simulated datasets with the 35 samples can be seen in Figure 4.1. From
Table 4.1, we see that as the estimated FDR values increase, more genes are identified
as being differentially expressed. For example, for n = 35, D = 50 and FDR = 0.05, 49
genes are identified and at FDR = 0.1 for the same n and D, 52 genes are identified. The
same pattern is seen for the other values of n. Table 4.2 shows the power of the copula
method at different estimated FDR levels for four sample sizes, n = 20, 35, 50 and 100.
The results show that the power of the copula method is sensitive to low sample sizes.
For example, the power is 0.58 when n = 20 at D = 50 but increases to 1 for the same
value of D as n increases to 100. For the sample size of at least 35, the least value of the
power observed from the analysis is 0.98. This shows that the copula method is quite
powerful in finding differentially expressed genes. The copula approach is also robust to
different sample sizes especially as the number of known DEGs increases.
Table 4.1: DEGs at FDR level between 0.001 to 1 on twelve simulated dataets each with
1000 genes. Sample size was set at n = (20, 35, 50 and 100). Number of significant
genes were set to be 50, 100 and 200.
Estimated FDR Threshold
n D 0.001 0.01 0.025 0.05 0.1 0.2
20 50 30 30 30 44 49 59
100 79 92 95 103 117 132
200 137 184 197 209 222 251
35 50 49 49 52 53 54 62
100 99 101 101 105 110 121
200 201 201 204 209 222 258
50 50 50 50 51 51 53 61
100 100 101 102 106 112 124
200 202 205 210 216 223 249
100 50 50 50 50 50 55 58
100 100 101 101 107 111 136
200 201 201 208 212 226 259
When applied to the cell lines dataset, the copula method identified 9 genes at FDR
< 0.01 and 25 genes at FDR < 0.2 for G2. Table 4.3 lists the genes that are correlated
with G2 checkpoint function at FDR < 0.2. We compare our results and the results
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Figure 4.1: Heatmaps of simulated data. Simulated data contain 1000 genes and 35
samples. In (a) No assumption is made of the number of DEGs, in (b) 50 genes, in (c)
100 genes and in (d) 200 genes , are assumed to be correlated with quantitative outcome.
presented in the paper by Omolo et al. (2013). This paper also selected genes based on
G2 checkpoint function. They found 165 genes that were correlated with G2. These 165
were unique genes generated by two methods; Bayesian and quantitative trait analysis
(QTA). The intersection between our 25 genelist and their 165 genelist generated 3 genes
namely ZNF711, DGKE and ARNTL2. The intersection results are in Figure 4.2. It is
important to note that the QTA method applied in the paper by Omolo et al. (2013)
did not adjust for multiplicity. Therefore, a direct comparison of the two genlists, 165
genelist and our 25 genelist, may not be appropriate.
The results from the LASSO analysis show that the copula genelist can be used
to predict the G2 checkpoint function (r = 0.558, p = 0.004939). The coefficient of
determination was however low (r2 = 0.31). We further subjected our genelist to a
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Table 4.2: Power at FDR level between 0.001 to 1 on six simulated datasets each with
1000 genes. Sample size was set at n = (20, 35, 50 and 100). Number of significant
genes were set to be 50, 100 and 200.
Estimated FDR Threshold
n D 0.001 0.01 0.025 0.05 0.1 0.2
20 50 0.58 0.58 0.58 0.80 0.88 0.96
100 0.79 0.92 0.95 0.98 0.99 1.00
200 0.69 0.92 0.98 1.00 1.00 1.00
35 50 0.98 0.98 1.00 1.00 1.00 1.00
100 0.99 1.00 1.00 1.00 1.00 1.00
200 1.00 1.00 1.00 1.00 1.00 1.00
50 50 1.00 1.00 1.00 1.00 1.00 1.00
100 1.00 1.00 1.00 1.00 1.00 1.00
200 1.00 1.00 1.00 1.00 1.00 1.00
100 50 1.00 1.00 1.00 1.00 1.00 1.00
100 1.00 1.00 1.00 1.00 1.00 1.00
200 1.00 1.00 1.00 1.00 1.00 1.00
survival risk prediction analysis to asses its biological importance. Our list generated 4
prognostic genes which shows a significant separation of the samples into low and high
risk group (χ2 = 5.9 p = 0.0147). See results in Figure 4.4. An almost similar results were
seen in Omolo et al. (2013) for their 32 prognostic genes (χ2 = 5.6 p = 0.018). Our list of
25 genes performs better in SRP than any randomly selected 25 genes from the 3860 genes
(χ2 = 0.1 p = 0.655). Unsupervised hierarchical clustering indicate no significant (p-value
= 0.317) separation of the incidences of distance metastasis (Fig.4.4). Intersecting the
prognostic genes from these two studies, only one gene, ZNF711, is generated. This gene,
however, has not been previously reported in relation to melanoma development. It lies
in a region of the X chromosome which has been associated with mental retardation
(Tarpey et al., 2009).
4.6 Conclusion
In this chapter, we have proposed a copula-based algorithm for finding differentially
expressed genes when the outcome of interest is continuous. In the proposal, a nor-
mal copula is employed in the analysis. We have shown the potential of the proposed
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Table 4.3: List of genes that are correlated with G2 checkpoint function as selected by
the copula approach at FDR < 0.2
Agilent ID Symbol Gene Name
A 23 P14612 FGF7 fibroblast growth factor 7(FGF7)
A 23 P153964 INHBB inhibin beta B subunit(INHBB)
A 23 P203115 TMEM25 transmembrane protein 25(TMEM25)
A 23 P211631 FBLN1 fibulin 1(FBLN1)
A 23 P214080 EGR1 early growth response 1(EGR1)
A 23 P217297 ZNF711 zinc finger protein 711(ZNF711)
A 23 P364504 ERFE erythroferrone(ERFE)
A 23 P369328 C10orf35 chromosome 10 open reading frame 35(C10orf35)
A 23 P389250 Smco2 single-pass membrane protein with coiled-coil domains 2(SMCO2)
A 23 P393034 HAS3 hyaluronan synthase 3(HAS3)
A 23 P69537 NMU neuromedin U(NMU)
A 24 P130952 MLK4 mixed lineage kinase 4(MLK4)
A 24 P196665 GNGT1 G protein subunit gamma transducin 1(GNGT1)
A 24 P20814 KHDC1L KH domain containing 1 like(KHDC1L)
A 32 P209230 CITED4 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-
terminal domain 4(CITED4)
A 32 P232559 PRKCQ-AS1 PRKCQ antisense RNA 1(PRKCQ-AS1)
A 32 P399546 ARNTL2 aryl hydrocarbon receptor nuclear translocator like 2(ARNTL2)
A 32 P540991 DGKE diacylglycerol kinase epsilon(DGKE)
A 23 P153958 Unknown Unknown
A 32 P134427 Unknown Unknown
A 32 P154726 Unknown Unknown
A 32 P190343 Unknown Unknown
A 32 P227158 Unknown Unknown
A 32 P874394 Unknown Unknown
A 32 P30874 Unknown Unknown
copula-based approach in finding genes that are correlated with quantitative outcome
in melanoma studies. The main focus was on demonstrating how powerful the copula
method is in selecting genes that are correlated with quantitative outcome while control-
ling for FDR. Simulations indicated that the copula-based model had reasonable power
at various levels of the FDR. Our approach is flexible as no parametric assumption is
made on the marginal distribution except that they are continuous. Relaxing parametric
assumptions on microarray data may yield procedures that have good power for selecting
differentially expressed genes. Although the methodology was motivated by data from
the agilent technology, it can be adopted for data from any technology where both the
gene expression levels and the outcome of interest are continuous.
New technologies such as RNA-sequencing (RNA-seq) are slowly replacing micoraary
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Figure 4.2: Venn diagrams of genes from different genelists .(a) Intersection of
copula G2 25 genes and 165 from Omolo et al.,(2013) (b) Intersection of Cox genes, 4
copula list and 34 list from Omolo et al.,(2013).
technology. Current methods being developed for differential gene expression analysis are
focusing on RNA-seq data. However, RNA-seq is more costly than microarrays (Bair,
2013). For a quick and easy experiment, microarrays can provide reliable and sensitive
results. Therefore, new methods for analysing data from microarrays is till relevant and
timely. Comparison of the proposed copula-based approach with the existing methods is
done in the next chapter. We will also demonstrate how to choose an optimal copula for
real microarray dataset.
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Figure 4.3: A scatter plot for actual values ofG2 values verses predicted values. Prediction
of G2 values were done using LASSO with LOOCV method.
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Figure 4.4: Kaplan-Meier survival plot and heatmap for the copula gene signa-
ture. (A): Unsupervised hierarchical cluster of 58 samples using the 25 copula genes that
were correlated with G2 checkpoint function. The classification of the samples yielded
non-significant results (χ2 = 1.0025, p = 0.317) . (B): The separation of the two groups
in the Kaplan-Meier survival plot was significant (χ2 = 5.9, p = 0.0147).
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Chapter 5
Comparison of the Copula Model
with the QTA for Microarray
Analysis
In this chapter we compare the copula-based approach for finding DEGs with the QTA
method described in Chapter 2 by use of a simulation study. The QTA method was
found to be a better method for finding genes that are good predictors of a quantitative
outcome (Chaba et al., 2017). We use power and control of Type I error as the main
basis of the comparison. These two measurements may indicate how the copula-based
approach performs in comparison with the QTA method.
5.1 Which Copula to Use?
Having an appropriate copula in copula modelling is very crucial. To date, no study
has been conducted on choosing the best copula model for gene expression data analysis.
In the literature where the copula is applied on gene expression data, the choice of the
copula is done arbitrarily. Some authors chose the copula based on how convenient they
were for the analysis (Owzar et al., 2007). Others like Yuan et al. (2008) chose the copula
based on the value of the likelihood. They chose the copula with the largest likelihood.
With several copulas to choose from in empirical applications, one needs an appro-
priate one for the data at hand. The statistical features of the data should guide the
selection of the copulas. For example, gene expression profiles can be positively or neg-
atively associated with a quantitative outcome. Therefore, naturally, copulas that can
capture both the negative and the positive dependence such as the Normal copula, the
Student-t copula and the Frank copula should be superior to the Gumbel and Clayton
copulas, which do not permit negative dependence. To this end, we recommend the
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following procedure:
1. Perform copula model selection based on the existing methods on all the pairs (a
quantitative outcome and each gene expression profile). This helps in determining
the closest parametric copula family from the list of copulas provided.
2. Record the proportion of pairs that are fitted by different parametric copulas.
3. The copula that fits most of the pairs is assumed for the whole analysis.
We consider two copulas: the Normal copula and the Frank copula, since they permit
both positive and negative dependence. We perform model selection based on the AIC
and the BIC, using the melanoma cell lines dataset. The Student-t copula is close to
Normal copula, hence was not considered. The copula that fits the highest proportion of
the pairs is adopted for the comparison of the two gene selection methods. The goodness-
of-fit-test for the two copulas was also performed, using the Cramer-Von Mises (CVM)
function Genest et al. (2009). Given the results in Table 5.1, the normal copula is the
best of the two and will be used in the comparison.
Table 5.1: Copula model selection based on three methods.




5.2 Simulated Gene Expression Data
Let n and G denote the number of samples and genes, respectively. Further, let D denote
the number of genes assumed to be truly differentially expressed. Then (G − D) genes
are assumed to be non-differentially expressed. The gene expression data matrix, X, is a
G×n matrix of log2-ratios. We can write X as X = (X1,X2), where X1 and X2 are D×n
and (G−D)× n matrices, respectively. We set D ∈ (50, 100, 200, 300, 400), n = 35 and
G to be 1000. We generated the (1000−D) genes from the standard normal distribution.
To generate the D genes, we used the standard normal distribution in conjunction with
the Cholesky decomposition (Golub and Van Loan, 1996) of their correlation matrix as
follows:
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1. We generate an unstructured correlation matrix Ω. Ω is a (D+1)× (D+1) matrix
that has (i, j)th element given by ωi,j = corr(xi, xj)
2. Find the Cholesky factor, A, of Ω such that Ω = AA′.
3. Let zi ∼ N(0, In), i = 1, 2, ..., (D + 1).
4. Z = (z1, z2, ..., zD+1)
′
5. XD+1 = AZ. XD+1 is the gene expression matrix for D genes assumed to be
differentially expressed and a covariate y. y can take any of the D + 1 row vectors
from the matrix XD+1. X1 is therefore a submatrix of XD+1 with dimensions D×n.
This simulation set-up assumes that each gene is observed across each sample. We com-
pare our copula-based approach with the QTA method.
5.2.1 Simulation Results
Table 5.2 reports the number of genes declared to be differentially expressed for the copula
and the QTA methods at different levels of FDR threshhold. The results indicate that, in
general the copula method identified more DEGs than the QTA method. We note that
the identified DEGs is likely to include both the truly DEGs and the false positives.
In order to evaluate the two methods in terms of power, the number of DEGs and the
number of truly DEGs were recorded. The power was then calculated as the ratio of the
number of truly DEGs to the total number of known DEGs. Power comparison results
are shown in Table 5.3. Both the copula and the QTA methods have sufficient power to
detect DEGs with a power of 1 in most cases. A power of 1 means that the method is
able to detect all the known DEGs. In cases where the power was different for the two
methods, the copula method stood out. This is seen especially when D = 200.
Controlling Type I error here means having an empirical Type I error close to the
nominal level of the test. The closer the empirical Type I error is to the set nominal
level, the better the method in controlling it. Table 5.4 shows that both the methods
have reasonably controlled for Type I error at different nominal levels. There is evidence
of both over and under estimation of the nominal levels by both methods although the
the deviations are minimal. We note that the copula method consistently estimated the
0.01 nominal level for all the values of D except for D = 50 as compared to the QTA
method. We also see that the accuracy of controlling the Type I error rate for the copula
method increases with the increase in the number of known DEGs. This means that,
even with a large number of DEGs identified by the copula method, we still trust the
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copula approach to properly control the Type I error rate. The closeness of the results for
the two methods on the simulated datasets may be due to the fact the data was gener-
ated from a normal distribution. Note that a bivariate Gaussian copula with two normal
marginals corresponds to a bivariate Gaussian distribution. As such, the copula param-
eter reduces to the linear correlation coefficient (Pearson’s correlation coefficient). The
QTA method calculates its p-values based on either the Pearson’s correlation coefficient
or the Spearman’s rho correlation coefficient.
Table 5.2: Number of DEGs by the copula and the QTA methods at different estimated
FDR levels.
Estimated FDR threshold
D Method 0.01 0.05 0.1 0.2
50 Copula 48 52 53 59
QTA 50 53 57 63
100 Copula 100 106 110 126
QTA 99 103 109 116
200 Copula 192 221 240 276
QTA 146 204 221 241
300 Copula 302 314 326 378
QTA 284 306 315 348
400 Copula 403 423 449 506
QTA 405 415 429 466
5.3 Real Data Analysis
In this section, we use the datasets described in the Chapter 2. To find DEGs, we apply
the same procedures for the QTA method and the copula method as described in Chapters
2 and 4 respectively. We note that the QTA method assumes normality on the marginal
as well as linearity on the relationship between two variables. This is not always the case
especially for gene expression levels data. In Figure 5.1, none of the randomly selected
genes showed a linear relationship with the G2 checkpoint function.
Table 5.5 shows the number of DEGs identified by the copula and the QTA methods
based on the melanoma cell lines data and the G2 checkpoint function as the quantita-
tive outcome. In detecting DEGs using the real melanoma dataset, the copula method
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Table 5.3: Power comparison for the copula method and the QTA method for different
nominal level and different number of known DEGs
Estimated FDR threshold
D Method 0.01 0.05 0.1 0.2
50 Copula 0.96 1.00 1.00 1.00
QTA 1.00 1.00 1.00 1.00
100 Copula 0.99 1.00 1.00 1.00
QTA 0.99 1.00 1.00 1.00
200 Copula 0.95 1.00 1.00 1.00
QTA 0.72 0.97 1.00 1.00
300 Copula 1.00 1.00 1.00 1.00
QTA 0.94 0.99 1.00 1.00
400 Copula 1.00 1.00 1.00 1.00
QTA 1.00 1.00 1.00 1.00
Table 5.4: Type I error rates of our method compared to the QTA method for different
nominal level and different number of known DEGs
Estimated FDR threshold
D Method 0.01 0.05 0.1 0.2
50 Copula 0.00 0.04 0.06 0.15
QTA 0.00 0.06 0.12 0.21
100 Copula 0.01 0.06 0.09 0.21
QTA 0.00 0.03 0.08 0.14
200 Copula 0.01 0.10 0.17 0.28
QTA 0.02 0.05 0.10 0.17
300 Copula 0.01 0.04 0.08 0.21
QTA 0.00 0.03 0.05 0.14
400 Copula 0.01 0.05 0.11 0.21
QTA 0.01 0.04 0.07 0.14
identifies more DEGs than the QTA especially at very low FDR thresholds. However
as the FDR increases, QTA identifies more DEGs than the copula method. Figure 5.2
shows that an intesection of the genelists generated by the two methods yields 11 (15.7%)
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Figure 5.1: Expression profiles of a few genes as a function of the quantitative outcome
(G2). Gene expressions are associated with the G2 in a nonlinear manner.
common genes. The results also indicate that the copula approach is a better predictor of
a sample being in either low or high risk group of developing distant metastasis than the
QTA method. QTA however shows better results in predicting G2 checkpoint function
than the copula method.
64
Chapter 5. Comparison of the Copulas and the QTA Methods
Table 5.5: Number of genes declared differentially expressed using the copula method
and the QTA method on the melanoma cell lines dataset, prediction results based on the
LASSO with LOOCV and the survival risk prediction results based on log rank test are
also provided
Estimated FDR threshhold Prediction of G2 SRP
Method 0.01 0.05 0.1 0.2 r p-value Chis p-value
Copula 9 9 9 25 0.5 0.0022 6.7 0.0096
QTA 0 0 4 56 0.721 <0.001 4.8 0.0374
Figure 5.2: Number of overlapping genes from the copula and the QTA genelists based
on the melanoma cell lines dataset.
5.4 Conclusion
This chapter presents a comparison of our proposed copula-based approach with the QTA
method for finding differentially expressed genes when the outcome is continuous in na-
ture. Using the power and the control of Type I error as a baseline for comparison, both
methods perform well in power comparison but the copula approach was notably the
better. In terms of the Type I error rate control, the two methods are comparable. We
have also proposed a simple way of choosing a copula for gene expression studies. This
approach is however limited to the copulas that permit both negative and positive depen-
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dence only, and therefore better methods need to be developed. Both the copula method
and the QTA are useful in generating gene signatures that are clinically important.
It is reasonable to conclude that, based on the current study, a semi-parametric copula
approach outperform a QTA model which is parametric, in noisy high-dimensional data
settings like in microarray studies. Here, however, we are limited to the QTA model,
but other parametric models do exist (e.g. Bayesian models, etc.). It would therefore
be interesting to see how semi-parametric models perform when compared to Bayesian





We have proposed a new algorithm for finding differentially expressed genes based on
the copula functions. The main purpose was to develop a new procedure that is able to
identify genes that are correlated with a quantitative outcome. The developed algorithm
was evaluated using simulated datastes and applied on the real datasets for validation.
We have shown that our proposed method has a good power to select DEGs and controlled
the Type I error rate well for the settings we considered. We have also demonstrated the
effectiveness of our copula-based approach in the analysis of a real data set. The genelist
generated by our proposed approach is a good predictor of a quantitative outcome and
is prognostic. The identification of such types of genes may lead to a more accurate
diagnostics and treatment at individual patient level. In general, the simulation and
data analysis results suggest that the proposed copula-based algorithm is a promising
approach in differential gene expression analysis.
Prior to our proposal, we evaluated and compared four existing methods for finding
genes when the outcome of interest is continuous. These four methods are the SAM,
the LIMMA, the LPC and the QTA. The main reason for performing the evaluation
was to find the “best” performing method to be compared with our proposed copula
method. In this regard, the QTA approach was selected based on its predictive ability.
We have shown that the algorithm proposed outperforms the QTA in terms of power,
but the performance is comparable in terms of Type I error rate control. Compared with
existing methods, our method is flexible in that one does not need to specify the marginal
distribution as long as it is continuous. From all the comparative analysis in this study, it





This is the first time this approach is applied to the analysis of gene expression data with
a quantitative outcome. Therefore, issues are expected to arise and they will need to be
addressed. The major downside of our algorithm is the high computational burden it
bears as the size of the gene expression data gets large. This is because the gene specific
p-values are calculated using permutation resampling method. The higher the number
of permutations, the slower the process. The second drawback is the use of an assumed
copula for the analysis of the whole dataset. The dependence structure between each gene
expression level and any quantitative outcome is not fixed, but rather vary from one gene
to the other. Therefore, using an assumed parametric copula to model the dependence
of all pairs may not be appropriate even after choosing an optimal copula based on the
steps provided in this work. We have also assumed that genes are independent. This is
not always true for microaray studies as genes are believed to work together in a pathway.
6.3 Possible Extensions
Choosing the best copula to find genes that are correlated with quantitative trait is still an
open field and more studies need to be conducted in this area. It would also be interesting
to extend the copula-based approach to finding differentially expressed genes expression
for RNA-sequencing (RNA-seq) dataset which is discrete in nature. This should be done
with caution since there does not exist a unique copula identifying the joint distribution




A bivariate Normal Copula
A bivariate normal copula is expressed as




















is the bivariate standard normal distribution function with the correlation parameter












dx i = 1, 2 (6.3)
denotes the univariate standard normal distribution function. We find probability density
function of copula, c(u1, u2; θ) by differentiating the C(u1, u2; θ) with respect to u1 and
u2. i.e.




Let qi = Φ
−1(ui). Therefore,






















Equation 6.5 therefore becomes











The copula density function thus becomes



















and the likelihood function in terms of the normal copula is





































#For n=35 and D=50. The rest of the setting is carried out using the sam
approach
###################################################################
x1 <- matrix(rnorm(35*950), nrow=950)
require(Matrix)
#Generating a correlation matrix:
###################################################################
R <- matrix(runif(51*51), ncol=51)
RtR <- R %*% t(R)







random.normal = matrix(rnorm(nvars*numobs,0,1), nrow=nvars, ncol=numobs);
x2 = U %*% random.normal
class(x2)
#######################################




Exp=rbind(x2[2:51,],x1[1:950,])#with genes on the rows and samples on the columns
plot_ly(z = Exp, type = "heatmap")#ploting heatmap
tExp=t(Exp)#with genes on the columns and samples on the rows
write.csv(tExp,file="tExp2.csv")















g2=read.csv("g2.csv",row.names=1) y=g2[,1]# vector of quantitative outcomes
x=read.csv("NewFiltered35ArrayDataG2.csv",row.names=1) #A matrix of gene
expression data (3860 genes)
###############################################################################
#function for calculating copula parameter. Use mpl method. Matrix chosen to
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be exchangeable. #The dispersion matrix won’t be a big deal even if its






























































#Reading in the data
###################################################################
x=read.csv("NewFiltered35ArrayDataG2.csv",row.names = 1)# Expression values
data with column one as the gene ID
x1=x[,1:35]#Getting just the expression data without the rownames
x1=as.matrix(x1)#Samr needs data in matrix format and not data frame
y=read.csv("g2.csv",row.names=1)#Bringing in outcome data. Excel file with
sample names, and two outcomes
attach(y)























#Reading in the data
####################################################################
x=read.csv("NewFiltered35ArrayDataG2.csv",row.names = 1)# Expression values
data with column one as the gene ID
x1=x[,1:35]#Getting just the expression data without the rownames
x1=as.matrix(x1)#Samr needs data in matrix format and not data frame
y=read.csv("g2.csv",row.names=1)#Bringing in outcome data. Excel file with
76
Appendices
sample names, and two outcomes
attach(y)








eset=t(y1)#Transpose covariate, format required by limma
#MA is expression data only
MA=x[,1:35]
#Creating a design matrix. Limma needs specification of design matrix.
This requires spline package
##################################################################
require(splines)
X <- ns(eset, df=5)
design <- model.matrix(~X)
#fitting the model
fit <- lmFit(MA, design)
fit <- eBayes(fit)
#Getting top significant genes based on fdr value of
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